# Erythropoietin in Hemolytic Uremic Syndrome

> **NCT03776851** · PHASE4 · COMPLETED · sponsor: **Hospital General de Niños Pedro de Elizalde** · enrollment: 24 (actual)

## Conditions studied

- Hemolytic-Uremic Syndrome
- Anemia

## Interventions

- **DRUG:** erythropoietin

## Key facts

- **NCT ID:** NCT03776851
- **Lead sponsor:** Hospital General de Niños Pedro de Elizalde
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03776851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03776851, "Erythropoietin in Hemolytic Uremic Syndrome". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03776851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*